C2C contributed to an article on Sickle Cell Disease treatment in the prestigious medical journal Lancet Haematology.
In our Ahmedabad partner center 95% cure of children with thalassemia
Our experience in BMT services set up in middle income countries drives European Blood and Marrow Transplantation group stand on the approach to the cure of pediatric disorder in reduced resources settings..
C2C has reached out to 10.000 children with severe blood disorders and cancer globally.
The Center for International Blood and Marrow Transplant Research (CIBMTR) Awarded to the work of Cure2Children for expanding the availability of transplantation.
A pilot educational program by the Outreach Subcommittee, Paediatric Diseases Working Party - EBMT, supported by DKMS and Cure2Children.